Chase LoPriore

Director at Hepion Pharmaceuticals.

Red Bank, NJ
Hepion Pharmaceuticals

Raised on Hepion Pharmaceuticals filings

$3.8M

of $3.8M offered across 2 Form D filings

Form D filings: 2
Teammates: 7
Last filing: Aug 5, 2026

Company

Hepion Pharmaceuticals

Biotech · Red Bank, NJ

Blood tests for early liver cancer detection

Blood tests for early liver cancer detection

Investors: 33

Investors: 33
Sector: Biotech
HQ: Red Bank, NJ

Hepion Pharmaceuticals filings

Hepion Pharmaceuticals Form D filings
Filed	Security	Sold of offered	Filing
Aug 5, 2026	Equity	$3.1M/ $3.1M	Form D
Apr 22, 2026	Equity	$700K/ $700K	Form D

EquityFiled Aug 5, 2026Form D
$3.1M/ $3.1M
EquityFiled Apr 22, 2026Form D
$700K/ $700K

Works with

Also named on Hepion Pharmaceuticals filings

Gary StetzInterim Chief Executive Officer, Form D signerForm D signer Gary Stetz, IIDirector Timothy BlockDirector Dania FisherDirector Michael PurcellDirector Sireesh AppajosyulaDirector Vincent LoPrioreExecutive Chairman